Casdin Capital, LLC Standard Biotools Inc. Transaction History
Casdin Capital, LLC
- $1.16 Billion
- Q4 2024
A detailed history of Casdin Capital, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 71,254,677 shares of LAB stock, worth $96.2 Million. This represents 10.73% of its overall portfolio holdings.
Number of Shares
71,254,677
Previous 71,254,677
-0.0%
Holding current value
$96.2 Million
Previous $138 Million
9.33%
% of portfolio
10.73%
Previous 10.68%
Shares
4 transactions
Others Institutions Holding LAB
# of Institutions
143Shares Held
274MCall Options Held
6.7KPut Options Held
48.7K-
Viking Global Investors LP58.7MShares$79.2 Million0.35% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$29.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$23.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY16.9MShares$22.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny7.08MShares$9.56 Million0.01% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $106M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...